Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

32.44
Delayed Data
As of Feb 09
 -0.26 / -0.80%
Today’s Change
31.83
Today|||52-Week Range
52.10
-24.13%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close32.70
Today’s open32.25
Day’s range31.87 - 33.63
Volume507,064
Average volume (3 months)759,684
Market cap$2.3B
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)-3.94%
Earnings growth (next 5 years)+24.96%
Revenue growth (last year)+16.53%
P/E ratio84.6
Price/Sales3.75
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...+0.18+0.19%
MYGNMyriad Genetics Inc-0.38-1.09%
HZNPHorizon Pharma PLC+0.13+0.81%
MDCOMedicines Co+0.45+1.55%
Data as of 02/09/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

Partner Offers